According to Vision Research Report Reports, the global Surgical Sutures market size was valued at US$ 4.1 Bn in 2021 and is expected to grow at a CAGR of 5.7%% from 2022 to 2030.
Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/39144
Growth Factors
The market growth can be attributed to a rise in surgical procedures due to an increasing number of cardiac diseases and orthopedic injuries, which occur due to the increasing geriatric population as well as the rising number of accidents. The lifestyle changes, growing healthcare expenditure, favorable reimbursement scenarios, and government support to improve the healthcare infrastructure are also significant factors contributing to the growth of the market.
The rise in healthcare expenditure by most countries and improving healthcare infrastructure in emerging economies are expected to promote patient footfall. In addition, technological advancement by key players helps to initiate more precise procedures, which increases the success rate of surgery. This is also leading to the growth of the market for surgical sutures.
Report Coverage
Report Scope | Details |
Market Size | US$ 6.4 billion by 2030 |
Growth Rate | CAGR of 5.7% From 2022 to 2030 |
Largest Market | North America |
Base Year | 2021 |
Forecast Period | 2022 to 2030 |
Segments Covered | Type, Filament, Application |
Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Companies Mentioned | Covidien; Ethicon US, LLC. (Johnson & Johnson Services, Inc.); B. Braun Melsungen AG; Smith & Nephew; Integra Lifesciences; Peter Surgical; Internacional farmaceutica; CONMED CORPORATION; Sutures India Pvt. Ltd |
By Type Analysis
The absorbable segment held the largest revenue share of over 55.0% in 2021 owing to its ability to provide temporary support to wounds till it heals and can withstand normal stress. Moreover, the demand for absorbable sutures is continuously rising, which can be attributed to their ability to degrade naturally.
Non-absorbable sutures accounted for a lower market share in comparison to absorbable sutures due to their inability to degrade or breakdown. These sutures are majorly used in the stressful internal environment where absorbable sutures are not able to fulfill the desired requirement.
By Filament Analysis
The multifilament segment dominated the market for surgical sutures with a revenue share of over 55.0% in 2021. The multifilament segment is also expected to witness the fastest growth during the forecast period. This can be attributed to advantages associated with the multifilament segment such as better pliability, high tensile strength, and flexibility.
Monofilament sutures are difficult to handle and may cause crushing or crimping of the suture and lead to undesirable and premature suture failure during surgery due to their memory. The monofilament sutures are made up of materials such as monocryl, nylon, prolene, and polydioxanone.
By Application Analysis
The others segment dominated the market for surgical sutures and held a revenue share of over 35.0% in 2021. The cardiovascular surgery segment held the second-largest revenue share in 2021. This is owing to the high incidence of cardiac diseases, the presence of sufficient experts in the field, supportive reimbursement scenarios, and advancement in diagnostics.
The orthopedic surgery segment emerged as the third-largest application segment in 2021 and is expected to witness lucrative growth over the forecast period. This is due to the growing number of road accidents that are leading to a rise in the number of orthopedic injuries
By Regional Analysis
The North American region dominated the market for surgical sutures in 2021 with a revenue share of over 40.0% owing to the presence of local and key players, high cost of sutures as compared to other regions, supportive reimbursement scenario, rising government programs, and developed healthcare infrastructure.
Asia Pacific is expected to witness the fastest growth during the forecast period. This is due to the growing geriatric population base that is more likely to go under surgery and increase in government spending on the healthcare infrastructure to meet the unmet needs in this region.
Key Players
- Covidien
- Ethicon US, LLC. (Johnson & Johnson Services, Inc.)
- B. Braun Melsungen AG
- Smith & Nephew
- Integra Lifesciences
- Peter Surgical
- Internacional farmaceutica
- CONMED CORPORATION
- Sutures India Pvt. Ltd.
Market Segmentation
- By Type
- Absorbable
- Non-absorbable
- By Filament
- Monofilament
- Multifilament
- By Application
- Ophthalmic Surgery
- Cardiovascular Surgery
- Orthopedic Surgery
- Neurological Surgery
- Others
- Regional
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Asia Pacific
- Japan
- China
- India
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- North America
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Surgical Sutures Market, By Type
7.1. Surgical Sutures Market, by Type, 2021-2030
7.1.1. Absorbable
7.1.1.1. Market Revenue and Forecast (2019-2030)
7.1.2. Non-absorbable
7.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 8. Global Surgical Sutures Market, By Filament
8.1. Surgical Sutures Market, by Filament, 2021-2030
8.1.1. Monofilament
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Multifilament
8.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Surgical Sutures Market, By Application
9.1. Surgical Sutures Market, by Application, 2021-2030
9.1.1. Ophthalmic Surgery
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Cardiovascular Surgery
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Orthopedic Surgery
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Neurological Surgery
9.1.4.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Surgical Sutures Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Type (2019-2030)
10.1.2. Market Revenue and Forecast, by Filament (2019-2030)
10.1.3. Market Revenue and Forecast, by Application (2019-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Type (2019-2030)
10.1.4.2. Market Revenue and Forecast, by Filament (2019-2030)
10.1.4.3. Market Revenue and Forecast, by Application (2019-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Type (2019-2030)
10.1.5.2. Market Revenue and Forecast, by Filament (2019-2030)
10.1.5.3. Market Revenue and Forecast, by Application (2019-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Type (2019-2030)
10.2.2. Market Revenue and Forecast, by Filament (2019-2030)
10.2.3. Market Revenue and Forecast, by Application (2019-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Type (2019-2030)
10.2.4.2. Market Revenue and Forecast, by Filament (2019-2030)
10.2.4.3. Market Revenue and Forecast, by Application (2019-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Type (2019-2030)
10.2.5.2. Market Revenue and Forecast, by Filament (2019-2030)
10.2.5.3. Market Revenue and Forecast, by Application (2019-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Type (2019-2030)
10.2.6.2. Market Revenue and Forecast, by Filament (2019-2030)
10.2.6.3. Market Revenue and Forecast, by Application (2019-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Type (2019-2030)
10.2.7.2. Market Revenue and Forecast, by Filament (2019-2030)
10.2.7.3. Market Revenue and Forecast, by Application (2019-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Type (2019-2030)
10.3.2. Market Revenue and Forecast, by Filament (2019-2030)
10.3.3. Market Revenue and Forecast, by Application (2019-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Type (2019-2030)
10.3.4.2. Market Revenue and Forecast, by Filament (2019-2030)
10.3.4.3. Market Revenue and Forecast, by Application (2019-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Type (2019-2030)
10.3.5.2. Market Revenue and Forecast, by Filament (2019-2030)
10.3.5.3. Market Revenue and Forecast, by Application (2019-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Type (2019-2030)
10.3.6.2. Market Revenue and Forecast, by Filament (2019-2030)
10.3.6.3. Market Revenue and Forecast, by Application (2019-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Type (2019-2030)
10.3.7.2. Market Revenue and Forecast, by Filament (2019-2030)
10.3.7.3. Market Revenue and Forecast, by Application (2019-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Type (2019-2030)
10.4.2. Market Revenue and Forecast, by Filament (2019-2030)
10.4.3. Market Revenue and Forecast, by Application (2019-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Type (2019-2030)
10.4.4.2. Market Revenue and Forecast, by Filament (2019-2030)
10.4.4.3. Market Revenue and Forecast, by Application (2019-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Type (2019-2030)
10.4.5.2. Market Revenue and Forecast, by Filament (2019-2030)
10.4.5.3. Market Revenue and Forecast, by Application (2019-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Type (2019-2030)
10.4.6.2. Market Revenue and Forecast, by Filament (2019-2030)
10.4.6.3. Market Revenue and Forecast, by Application (2019-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Type (2019-2030)
10.4.7.2. Market Revenue and Forecast, by Filament (2019-2030)
10.4.7.3. Market Revenue and Forecast, by Application (2019-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Type (2019-2030)
10.5.2. Market Revenue and Forecast, by Filament (2019-2030)
10.5.3. Market Revenue and Forecast, by Application (2019-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Type (2019-2030)
10.5.4.2. Market Revenue and Forecast, by Filament (2019-2030)
10.5.4.3. Market Revenue and Forecast, by Application (2019-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Type (2019-2030)
10.5.5.2. Market Revenue and Forecast, by Filament (2019-2030)
10.5.5.3. Market Revenue and Forecast, by Application (2019-2030)
Chapter 11. Company Profiles
11.1. Covidien
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Ethicon US, LLC. (Johnson & Johnson Services, Inc.)
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. B. Braun Melsungen AG
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Smith & Nephew
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Integra Lifesciences
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Peter Surgical
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Internacional farmaceutica
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. CONMED CORPORATION
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Sutures India Pvt. Ltd.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
Glossary of Terms
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/39144
Contact Us:
Vision Research Reports
Call: +1 9197 992 333